Gaucher disease, the most prevalent glycolipid storage disorder, is classically subdivided into types according to the presence or absence of neurological involvement. Type I has hitherto been considered non-neuronopathic. We present six cases and a review of the literature of Parkinsonian symptoms in type I Gaucher disease patients. The hallmark of this atypical Parkinsonian syndrome is a relatively severe clinical course with early appearance of neurological signs in the 4th to 6th decade of life, aggressive progression of the signs and refractoriness to conventional anti-Parkinson therapy. We discuss the implications of these findings in the light of enzyme replacement therapy for Gaucher disease.
CITATION STYLE
Neudorfer, O., Giladi, N., Elstein, D., Abrahamov, A., Turezkite, T., Achai, E., … Zimran, A. (1996). Occurrence of Parkinson’s syndrome in type I Gaucher disease. QJM: An International Journal of Medicine, 89(9), 691–694. https://doi.org/10.1093/qjmed/89.9.691
Mendeley helps you to discover research relevant for your work.